Magnetic resonance outcome of new enhancing lesions in patients with relapsing-remitting multiple sclerosis

European Journal of Neurology

Volumn 6, Issue 4, 1999, Pages 455-459

  Ciccarelli, Olga ^a   Giugni, Elisabetta ^a   Paolillo, Andrea ^a   Mainero, Caterina ^a   Gasperini, Claudio ^b   Bastianello, Stefano ^a   Pozzilli, Carlo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAN CAMILLO FORLANINI HOSPITAL   (Italy)

Author keywords

Gadolinium enhancement; Magnetic resonance imaging; Multiple sclerosis; Natural history

Indexed keywords

GADOLINIUM;

ADOLESCENT; ADULT; ARTICLE; BRAIN INJURY; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; FEMALE; FOLLOW UP; HUMAN; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PRIORITY JOURNAL; RELAPSE; REMISSION;

EID: 0032778352     PISSN: 13515101     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-1331.1999.640455.x     Document Type: Article

References (32)

1. Barkhof F, Hommes OR, Scheltens P, Valk J (1991). Quantitative MRI changes in gadolinium-DTPA enhancement after high-dose intravenous methylprednisolone in multiple sclerosis. Neurology 41:1219-1222.
2. Barkhof F, McGowan JC, van Waesberghe JHTM, Grossman RI (1998). Hypointense multiple sclerosis lesions on TI-weighted spin-echo magnetic resonance images: their contribution in understanding multiple sclerosis evolution. J Neurol Neurosurg Psychiatry 64(Suppl):S77-S79.
3. Bastianello S, Pozzilli C, Bernardi S, Bozzao L, Fantozzi LM, Buttinelli C, Fieschi C (1990). Serial study of gadolinium-DTPA MRI enhancement in multiple sclerosis. Neurology 40:591-595.
4. Ferguson B, Matyszak MK, Esiri MM, Perry VH (1997). Axonal damage in acute multiple sclerosis lesions. Brain 120:393-399.
5. Filippi M, Rocca MA, Martino G, Horsfield MA, Comi G (1998a). Magnetization transfer changes in the normal appearing white matter precede the appearance of enhancing lesions in patients with multiple sclerosis. Ann Neurol 43:809-814.
6. Filippi M, Rocca MA, Rizzo G, Horsfield MA, Rovaris M, Minicucci L, et al. (1998b). Magnetization transfer ratios in multiple sclerosis lesions enhancing after different doses of gadolinium. Neurology 50:1289-1293.
7. Gasperini C, Pozzilli C, Bastianello S, Koudriavtseva T, Colleluori A, Millefiorini E, et al. (1996). The influence of clinical relapses and steroid therapy on the development of Gd-enhancing lesions: a longitudinal MRI study in relapsing-remitting multiple sclerosis patients. Acta Neurol Scand. 95:201-207.
8. Giugni E, Pozzilli C, Bastianello S, Gasperini C, Paolillo A, Koudriavtseva T, et al. (1997). MRI measures and their relations with clinical disability in relapsing-remitting and secondary progressive multiple sclerosis. Multiple Sclerosis 3:221-225.
9. Goodkin DE, Rudick RA, Ross JS (1994). The use of brain magnetic resonance imaging in multiple sclerosis. Arch Neurol 51:505-516.
10. Goodkin DE, Rooney WD, Sloan R, Bacchetti P, Gee L, Vermathen M, et al. (1998). A social study of new MS lesions and the white matter from which they arise. Neurology 51:1689-1697.
11. Grossman RI, Braffman BH, Brorson JR, Goldberg HI, Silberberg DH, Gonzalez-Searano F (1988). Multiple sclerosis: serial study of gadolinium-enhanced MR imaging. Radiology 169:117-122.
12. Guttmann CRG, Ahn SS, Hsu L, Kikins R, Jolesz FA (1995). The evolution of multiple sclerosis lesions on serial MR. Am J Neuroradiol 16:1481-1491.
13. Harris JO, Frank JA, Patrons N, McFarlin DE, McFarland HF (1991). Serial gadolinium-enhanced magnetic resonance imaging scans in patients with early, relapsing-remitting multiple sclerosis: implication for clinical trials and natural history. Ann Neurol 29:548-555.
14. Katz D, Taubenberger JK, Canella B, McFarlin DE, Raine CS, McFarland HF (1993). Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis. Ann Neurol 34:661-669.
15. Kurtzke JF (1983). Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444-1445.
16. Lai M, Hodgson T, Gawne-Cain M, Webb S, MacManus D, McDonald WI, et al. (1996). A preliminary study into the sensitivity of disease activity detection by serial weekly magnetic resonance imaging in multiple sclerosis. J Neurol Neurosurg Psychiatry 60:339-341.
17. McFarland HF, Frank JA, Albert PS, Smith ME, Martin R, Harris JO, et al. (1992). Using gadolinium-enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis. Ann Neurol 32:758-766.
18. Miller DH, Barkhof F, Nauta JJP (1993). Gadolinium enhancement increases the sensitivity of MRI in detecting disease activity in multiple sclerosis. Brain 116:1077-1094.
19. Miller DH, Albert PS, Barkhof F, Francis G, Frank JA, Hodgkinson S, et al. (1996). Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. Ann Neurol 39:6-16.
20. Miller DH, Grossman RI, Reingold SC, McFarland HF (1998). The role of magnetic resonance techniques in understanding and managing multiple sclerosis. Brain 121:3-24.
21. Paolillo A, Bastianello S, Frontoni M, Gasperini C, Giugni E, Ciccarelli O, et al. (1999). MR imaging outcome of new enhancing lesions lesions in relapsing-remitting multiple sclerosis patients treated with Interferonβ-1a. J Neurol: in press.
22. Poser CM, Paty D, Sheinberg L, McDonald WI, Davis FA, Ebers GC, et al. (1983). New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13:227-231.
23. Pozzilli C, Bastianello C, Koudriavtseva T, Gasperini C, Bozzao A, Millefiorini E, et al. (1996). Magnetic resonance imaging changes with recombinant human interferon β-1a: a short term study in relapsing-remitting multiple sclerosis patients. J Neurol Neurosurg Psychiatry 61:251-260.
24. Prineas JW, Barnard RO, Revesz T, Kwon EE, Sharer LR, Cho ES (1993). Multiple sclerosis. Pathology of recurrent lesions. Brain 116:681-693.
25. Smith ME, Stone LA, Albert PS, Frank JA, Martin R, Armstrong M, et al. (1993). Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine-enhancing magnetic resonance imaging lesions. Ann Neurol 33:480-489.
26. Thompson AJ, Miller D, Youl B, MacManus D, Moore S, Kingsley D, et al. (1992). Serial gadolinium-enhanced MRI in relapsing/remitting multiple sclerosis of varying disease duration. Neurology 42:60-63.
27. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L (1998). Axonal transection in the lesions of multiple sclerosis. New Engl J Med 338:278-285.
28. Truyen L, van Waesberghe JHTM, van Walderveen MAA, van Oosten BW, Polman CH, Hommes OR, et al. (1996). Accumulation of hypointense lesions ('black holes') on T1 spin-echo MRI correlates with disease progression in multiple sclerosis. Neurology 47:1469-1476.
29. van Waesberghe JHTM, van Walderveen MAA, Castelijns JA, Scheltens P, Lycklama à Nijeholt GJ, Polman CH, Barkhof F (1998). Patterns of lesion development in multiple sclerosis: longitudinal observations with T1-weighted spin-echo and magnetization transfer MR. Am J Neurol 19:675-683.
30. van Walderveen MAA, Barkhof F, Hommes OR, Polman CH, Tobi H, Frequin ST, Valk J (1995). Correlating MRI and clinical disease activity in multiple sclerosis: relevance of hypointense lesions on short-TR/short-TE (T1-weighted) spin-echo images. Neurology 45:1684-1690.
31. van Walderveen MAA, Kamphorst W, Scheltens P, van Waesberghe JHTM, Ravid R, Valk J, et al. (1998). Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis. Neurology 50:1282-1288.
32. Wicks DAG, Tofts PS, Miller DH, duBoulay GH, Feinstein A, Sacaras RH, et al. (1992). Volume measurement of multiple sclerosis lesions with magnetic resonance images. Neuroradiology 34:475-479.